Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Per-Anders Abrahamsson"'
Publikováno v:
European Urology Open Science, Vol 50, Iss , Pp 68-69 (2023)
Externí odkaz:
https://doaj.org/article/7f4003fb5bf64fa688cad62fb98f1f83
Publikováno v:
Asian Journal of Andrology, Vol 23, Iss 1, Pp 3-10 (2021)
Androgen deprivation therapy (ADT) with gonadotropin-releasing hormone (GnRH) agonists and antagonists is the mainstay of advanced prostate cancer treatment. Both drug classes decrease levels of luteinizing hormone and follicle-stimulating hormones (
Externí odkaz:
https://doaj.org/article/f7ca1625bec0410898b950ae280593cf
Autor:
Heather Johnson, Jinan Guo, Xuhui Zhang, Heqiu Zhang, Athanasios Simoulis, Alan H. B. Wu, Taolin Xia, Fei Li, Wanlong Tan, Allan Johnson, Nishtman Dizeyi, Per-Anders Abrahamsson, Lukas Kenner, Xiaoyan Feng, Chang Zou, Kefeng Xiao, Jenny L. Persson, Lingwu Chen
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-14 (2020)
Abstract Background Heterogeneity of prostate cancer (PCa) contributes to inaccurate cancer screening and diagnosis, unnecessary biopsies, and overtreatment. We intended to develop non-invasive urine tests for accurate PCa diagnosis to avoid unnecess
Externí odkaz:
https://doaj.org/article/e9f569944add4c5fa59d804e2aada290
Autor:
Sophie Chabot, Nishtman Dizeyi, Lena Ramnemark, Philippe Lluel, Per-Anders Abrahamsson, Magnus Grabe
Publikováno v:
Phytomedicine Plus, Vol 1, Iss 4, Pp 100057- (2021)
Background: Cernitin™ pollen extracts (brand name Cernilton®) alleviates symptoms related to common lower uro-genital tract disorders in men. The underlying mechanisms are ill-defined but the inflammatory pathway could be one of them. In a previou
Externí odkaz:
https://doaj.org/article/e777f6ffc0a24726a1962ea4871ce9be
Autor:
Jinan Guo, Xuhui Zhang, Taolin Xia, Heather Johnson, Xiaoyan Feng, Athanasios Simoulis, Alan H. B. Wu, Fei Li, Wanlong Tan, Allan Johnson, Nishtman Dizeyi, Per-Anders Abrahamsson, Lukas Kenner, Kefeng Xiao, Heqiu Zhang, Lingwu Chen, Chang Zou, Jenny L. Persson
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Objective: To avoid over-treatment of low-risk prostate cancer patients, it is important to identify clinically significant and insignificant cancer for treatment decision-making. However, no accurate test is currently available.Methods: To address t
Externí odkaz:
https://doaj.org/article/284b71b7c51548b3a7c43f959cdb2aee
Autor:
Jinan Guo, Heather Johnson, Xuhui Zhang, Xiaoyan Feng, Heqiu Zhang, Athanasios Simoulis, Alan HB Wu, Taolin Xia, Fei Li, Wanlong Tan, Allan Johnson, Nishtman Dizeyi, Per‐Anders Abrahamsson, Lukas Kenner, Lingwu Chen, Wanmei Zhong, Kefeng Xiao, Jenny L. Persson, Chang Zou
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 3, Pp n/a-n/a (2021)
Externí odkaz:
https://doaj.org/article/fe8a11bc1fb44379b760e90d4e4b862c
Autor:
Per-Anders Abrahamsson
Publikováno v:
Asian Journal of Urology, Vol 4, Iss 4, Pp 208-222 (2017)
Intermittent androgen deprivation therapy (IADT) is now being increasingly opted by the treating physicians and patients with prostate cancer. The most common reason driving this is the availability of an off-treatment period to the patients that pro
Externí odkaz:
https://doaj.org/article/201b55d95bc9459faf1ed359ada20969
Autor:
Martina Tinzl, Binshen Chen, Shao-Yong Chen, Julius Semenas, Per-Anders Abrahamsson, Nishtman Dizeyi
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0209544 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0079573.].
Externí odkaz:
https://doaj.org/article/a8f258e0fddf40f6a2a467d33ce262d5
Autor:
Marina G. Gobbo, Nishtman Dizeyi, Per-Anders Abrahamsson, Per-Anders Bertilsson, Viviane Sanches Masitéli, Eloisa Zanin Pytlowanciv, Sebastião R. Taboga, Rejane M. Góes
Publikováno v:
Journal of Diabetes Research, Vol 2015 (2015)
The antitumor properties of melatonin (MLT) are known for prostate cancer cells. This study investigated whether MLT affects prostate maturation and interferes with tissue injuries induced by diabetes. MLT was administered to Wistar rats from 5 weeks
Externí odkaz:
https://doaj.org/article/9c1bd47c167d4aa688f75b448673e533
Autor:
Martina Tinzl, Binshen Chen, Shao-Yong Chen, Julius Semenas, Per-Anders Abrahamsson, Nishtman Dizeyi
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79573 (2013)
Taxane based chemotherapy is the standard of care treatment in castration resistant prostate cancer (CRPC). There is convincing evidence that taxane therapy affects androgen receptor (AR) but the exact mechanisms have to be further elucidated. Our st
Externí odkaz:
https://doaj.org/article/c9fca333663a44018cb8abcfc2d52046